Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Kedrion Biopharma closes 2024 with a growth of +10% and unveils its new identity

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Kedrion-Growth-10pc

More Like This

Calliditas Therapeutics provides business update ahead of JP Morgan conference

Business Wire logo

Prothena Announces Corporate Restructuring

Business Wire logo

AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030

LifeArc Ventures 2024: new investments, targeted follow-ons and substantive portfolio progress

Immunovia Publishes Full Year Report for 2023

Hansa Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results

Allogeneic Cell Therapy to Treat Corneal Endothelial Disease (Graphic: Business Wire)

Aurion Biotech Launches Vyznova® (neltependocel) in Japan for the Treatment of Bullous Keratopathy of the Cornea

PR Newswire associated0

Quercus and Elionia close Eur 76 ml Financing for Construction of Three Biomethane Plants in Italy with a Syndicate of Banks

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us